Qin, Haixia
Zhang, Yan
Li, Shanshan
Ou, Yuanyuan
Lin, Shihuan
Lai, YinQi
Zhang, Qingping
Lai, Ziyan
Chen, Ya
Wu, Yuejuan
Liu, Zhen
Zhou, Kaixuan
Sun, Ruijing
Wu, Rongcai
Chen, Zhizhong
Zhang, Hui
Duan, Gaoxiong
Deng, Demao
Funding for this research was provided by:
Natural Science Foundation of Guangxi (2021GXNSFBA220007)
Guangxi key research and development program (AB22080053)
National Natural Science Foundation of China (No. 82060315)
Article History
Received: 26 April 2025
Accepted: 18 June 2025
First Online: 3 November 2025
Declarations
:
: The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration. The study was approved by the ethics committee of the People’s Hospital of Guangxi Zhuang Autonomous Region. This study was registered in the Chinese Clinical Trial Registry (ChiCTR1900020642) on 11th Jan 2019 ( .). Written informed consent was obtained from all participants after they had been given detailed information about the study.
: Not applicable.
: The authors declare no competing interests.